MetLife, Inc. (NYSE:MET - Get Free Report)'s share price passed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $99.05 and traded as low as $96.77. MetLife shares last traded at $97.6140, with a volume of 3,952,716 shares trading hands.
Wall Street Analysts Forecast Growth
Several research firms have commented on MET. Wells Fargo & Company increased their price objective on shares of MetLife from $110.00 to $113.00 and gave the company an "overweight" rating in a research report on Thursday, November 12th. Piper Sandler upped their target price on shares of MetLife from $110.00 to $115.00 and gave the company an "overweight" rating in a research report on Monday, November 9th. Jefferies Financial Group increased their price target on shares of MetLife from $103.00 to $115.00 and gave the company a "buy" rating in a report on Monday, August 10th. Keefe, Bruyette & Woods boosted their price objective on MetLife from $105.00 to $108.00 and gave the stock an "outperform" rating in a research note on Tuesday, August 11th. Finally, JPMorgan Chase & Co. upped their price objective on MetLife from $108.00 to $110.00 and gave the company an "overweight" rating in a research report on Thursday, October 15th. Fourteen equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $107.12.
View Our Latest Research Report on MET
MetLife Trading Down 2.2%
The firm has a market cap of $61.34 billion, a PE ratio of 12.73, a P/E/G ratio of 0.94 and a beta of 0.79. The company has a quick ratio of 0.21, a current ratio of 0.21 and a debt-to-equity ratio of 0.65. The company's 50 day moving average price is $99.05 and its two-hundred day moving average price is $87.34.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.78 EPS for the quarter, beating the consensus estimate of $2.77 by $0.01. MetLife had a net margin of 6.21% and a return on equity of 25.71%. The company had revenue of $20.52 billion for the quarter, compared to the consensus estimate of $19.86 billion. During the same period in the prior year, the firm posted $2.34 EPS. The firm's revenue was up 18.2% compared to the same quarter last year. As a group, sell-side analysts forecast that MetLife, Inc. will post 9.91 EPS for the current year.
MetLife Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be paid a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. MetLife's dividend payout ratio is currently 30.90%.
MetLife announced that its Board of Directors has authorized a stock repurchase program on Wednesday, August 5th that allows the company to buy back $3 billion in shares. This repurchase authorization allows the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its shares are undervalued.
Insider Activity
In related news, CEO Michel Khalaf sold 187,425 shares of the business's stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the completion of the transaction, the chief executive officer owned 759,013 shares in the company, valued at $78,155,568.61. The trade was a 19.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.40% of the company's stock.
Institutional Trading of MetLife
Institutional investors and hedge funds have recently made changes to their positions in the business. Defiance ETFs LLC purchased a new position in MetLife in the 3rd quarter worth about $235,000. Kestra Advisory Services LLC boosted its position in MetLife by 14.0% in the 3rd quarter. Kestra Advisory Services LLC now owns 65,008 shares of the financial services provider's stock valued at $6,121,000 after buying an additional 7,993 shares during the period. Advisors Asset Management Inc. purchased a new stake in MetLife in the 3rd quarter valued at about $3,834,000. Heartland Bank & Trust Co grew its stake in MetLife by 3.9% in the 3rd quarter. Heartland Bank & Trust Co now owns 6,502 shares of the financial services provider's stock worth $612,000 after acquiring an additional 246 shares in the last quarter. Finally, Innovator Capital Management LLC purchased a new position in shares of MetLife during the third quarter worth approximately $2,793,000. 94.99% of the stock is currently owned by institutional investors.
About MetLife
(
Get Free Report)
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.